当前位置:首页 / 穴位埋线联合桂香温经止痛胶囊治疗子宫内膜异位症的临床效果
论著.中医药与民族医药诊疗 | 更新时间:2024-01-10
|
穴位埋线联合桂香温经止痛胶囊治疗子宫内膜异位症的临床效果
Clinical effect of acupoint catgut embedding combined with Guixiang Wenjing Zhitong Capsules for the treatment of endometriosis

广西医学 2023第45卷20期 页码:2468-2474

作者机构:门佳囡,在读博士研究生,研究方向为中医药治疗不孕症等妇科杂病。

基金信息:黑龙江省卫生和计划生育委员会科研课题(2016-552)

  • 中文简介
  • 英文简介
  • 参考文献
目的探讨穴位埋线联合桂香温经止痛胶囊治疗子宫内膜异位症(EMT)的临床效果。方法将99例EMT患者随机分为观察组(n=52)和对照组(n=47)。两组患者均口服桂香温经止痛胶囊治疗,观察组患者同时接受穴位埋线治疗,两组均治疗3个月经周期。治疗前后比较两组患者的经期腹痛视觉模拟量表(VAS)评分、血清免疫因子[补体C3、IgA、IgG、IgM、抗子宫内膜抗体(EMAb)]水平、血清炎症因子[肿瘤坏死因子α(TNF-α)、基质金属蛋白酶9(MMP9)、血管内皮生长因子(VEGF)、糖类抗原125(CA125)]水平、性激素[卵泡刺激素(FSH)、黄体生成素(LH)、雌二醇]水平及血液流变学指标(全血高切黏度、全血低切黏度、全血还原黏度、血浆比黏度)。治疗后评估两组患者的临床疗效,观察治疗期间两组患者不良反应的发生情况。结果治疗后,两组经期腹痛VAS评分低于治疗前,且观察组经期腹痛VAS评分低于对照组(P<0.05)。治疗后,两组血清补体C3、IgA、IgG、IgM、EMAb、TNF-α、MMP9、VEGF、CA125、FSH、LH、雌二醇水平及全血高切黏度、全血低切黏度、全血还原黏度、血浆比黏度较治疗前降低(P<0.05),且观察组的上述指标水平低于对照组(P<0.05)。观察组治疗总有效率高于对照组(分别为92.54%、77.05%,P<0.05),两组不良反应发生率差异无统计学意义(P>0.05)。结论穴位埋线联合桂香温经止痛胶囊可能通过减轻免疫及炎症反应,改善性激素水平及血液流变学指标来减轻患者经期腹痛,治疗效果优于单纯桂香温经止痛胶囊治疗,且不良反应较少,值得临床推广。
ObjectiveTo explore the clinical effect of acupoint catgut embedding combined with Guixiang Wenjing Zhitong Capsules for the treatment of endometriosis (EMT). MethodsA total of 99 EMT patients were randomly divided into observation group (n=52) or control group (n=47). Patients in both groups were orally administrated Guixiang Wenjing Zhitong Capsules; simultaneously, the observation group received acupoint catgut embedding for treatment. Both groups received treatment for 3 menstrual cycles. The pre- and post-treatment Visual Analogue Scale score for abdominal pain during menstruation, serum immune factors (complement C3, IgA, IgG, IgM, and anti-endometrial antibody [EMAb]) levels, serum inflammatory factors (tumor necrosis factor α [TNF-α], metalloproteinase 9 [MMP9], vascular endothelial growth factor [VEGF], and carbohydrate antigen 125 [CA125]) levels, sex hormones (follicle-stimulating hormone [FSH], luteinizing hormone [LH], and estradiol) levels, and hemorheological indices (whole blood high shear viscosity, whole blood low shear viscosity, whole blood reduced viscosity, and plasma specific viscosity) were compared between patients of the two groups. The post-treatment clinical efficacy was evaluated in both groups, and the occurrence of adverse reactions during treatment was observed in patients of the two groups. ResultsAfter treatment, the VAS score for abdominal pain during menstruation was lower than that before treatment, and the observation group exhibited a lower VAS score for abdominal pain during menstruation as compared with the control group (P<0.05). After treatment, both groups yielded decreased levels of serum complement C3, IgA, IgG, IgM, EMAb, TNF-α, MMP9, VEGF, CA125, FSH, LH, and estradiol, as well as decreased whole blood high shear viscosity, whole blood low shear viscosity, whole blood reduced viscosity, and plasma specific viscosity as compared with before treatment (P<0.05); in addition, the observation group interpreted lower levels of indices as above as compared with the control group (P<0.05). The total effective rate of treatment in the observation group was higher than that in the control group (92.54% vs. 77.05%, P<0.05), furthermore, there was no statistically significant difference in the incidence late of adverse reactions between the two groups (P>0.05). ConclusionAcupoint catgut embedding combined with Guixiang Wenjing Zhitong Capsules can alleviate patients′ abdominal pain during menstruation through relieving immune and inflammatory responses, and ameliorating sex hormones levels and hemorheological indices, exerting superior therapeutic effect to simple Guixiang Wenjing Zhitong Capsules therapy and less adverse reactions, and it is worthy of clinical application.

1036

浏览量

160

下载量

0

CSCD

工具集